SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Munch-a-Biotech Today
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (1384)10/15/2002 8:27:32 PM
From: tuck  Read Replies (1) of 3158
 
A slightly odd fit, IMO; EBIO would have made more sense. Even though IVGN gets more cash than it paid for, the market doesn't seem enamored of this deal. IVGN was off on an otherwise good day. Might be the beginning of a buying op down the road, and maybe not too far. Instrument companies have been under pressure in the last couple of weeks, while reagent oriented companies seem to be hanging a little tougher. IVGN may report a half decent quarter.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News